首页> 外文期刊>Genetic Testing >Multiallelic Synthetic Quality Control Material: Lessons Learned from the Cystic Fibrosis External Quality Assessment Scheme
【24h】

Multiallelic Synthetic Quality Control Material: Lessons Learned from the Cystic Fibrosis External Quality Assessment Scheme

机译:多等位基因合成质量控制材料:囊性纤维化外部质量评估方案的经验教训

获取原文
获取原文并翻译 | 示例
       

摘要

With the arrival of increasingly complex molecular tests, we are obliged to create new ways to monitor and troubleshoot the underperformance of these multiplex assays. A synthetic multiallelic quality control material has been designed to augment genomic DNA controls. We aimed to evaluate the control on a large scale, testing it on a wide variety of oligonucleotide ligation assays, test protocols, and analysis software. In addition, we investigated how laboratories treat untried and complex materials. Methods: The synthetic control monitored 32 cystic fibrosis transmembrane conductance regulator mutations and polymorphisms simultaneously. Participants of a cystic fibrosis external quality assessment scheme were invited to analyze the quality control. Results: In total, 58 laboratories participated in this study. Twenty-seven (47%) laboratories detected 32 variants; another 27 laboratories (47%) detected from 31 to 4 variants and 4 participants reported no variants (6%). The main observations included administrative errors when indicating variants on a checklist, errors caused by misreading the instructions for use of the control or assay, and technical problems related to the assay used. Conclusion: Synthetic quality control materials proved to be valuable in troubleshooting underperforming assays and complement existing genomic controls. The study also revealed a strong need for increased quality control in the postanalytical phase of testing.
机译:随着日益复杂的分子测试的到来,我们有义务创造新的方法来监测和排除这些多重分析的性能不足。已经设计了合成的多等位基因质量控制材料来增强基因组DNA控制。我们旨在大规模评估该对照,并在各种寡核苷酸连接测定,测试方案和分析软件中对其进行测试。此外,我们调查了实验室如何处理未处理的复杂材料。方法:综合对照同时监测32个囊性纤维化跨膜电导调节子的突变和多态性。邀请了囊性纤维化外部质量评估计划的参与者来分析质量控制。结果:总共58个实验室参加了这项研究。二十七(47%)个实验室检测到32个变异。另外31个实验室(占47%)检测到31种到4种变异,有4名参与者报告无变异(6%)。主要观察结果包括在清单上指示变体时的管理错误,由于错误阅读对照或测定法使用说明而引起的错误以及与所用测定法有关的技术问题。结论:合成的质量控制材料被证明在排除表现不佳的检测方法和补充现有基因组控制方面很有价值。该研究还表明,在测试的分析后阶段,强烈需要加强质量控制。

著录项

  • 来源
    《Genetic Testing》 |2011年第9期|p.579-586|共8页
  • 作者单位

    Biomedical Quality Assurance Research Unit, Department of Human Genetics, University of Leuven, Leuven, Belgium;

    Molecular Controls, Sacred Heart Medical Center, Spokane, Washington;

    Molecular Controls, Sacred Heart Medical Center, Spokane, Washington;

    Molecular Controls, Sacred Heart Medical Center, Spokane, Washington;

    Our Lady's Children's Hospital, National Centre for Medical Genetics, Crumlin, Dublin, Ireland;

    Biomedical Quality Assurance Research Unit, Department of Human Genetics, University of Leuven, Leuven, Belgium;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:19:27

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号